Single-use bioprocessing is growing rapidly in 2026, but selecting the right solutions is becoming more complex
The bioprocessing industry continues to evolve at a rapid pace, driven by increasing demand for biologics, advances in technology and the need for more flexible manufacturing. Behind these developments are clear data points that define where the industry stands today — and where it is heading next.
Understanding these key statistics is essential for anyone operating in bioprocessing, biotechnology and (bio)pharmaceutical manufacturing — and for those looking to make the right decisions in an increasingly complex landscape.
A market defined by rapid growth
One of the most striking indicators is the continued expansion of the single-use bioprocessing market. According to Mordor Intelligence, the market is projected to grow at a compound annual growth rate (CAGR) of approximately 15.2% in the coming years. This sustained double-digit growth positions single-use technologies as one of the fastest-growing segments in biomanufacturing. It is driven by increasing demand for biologics, vaccines and advanced therapies, combined with the need for faster and more flexible production environments.
This rapid growth raises important questions: how do you select the right technologies, and how do you position your organisation within this expanding market? These are exactly the types of questions that benefit from direct discussion with industry peers and suppliers — something that remains difficult to achieve through data alone.
Scaling biologics and advanced therapies
The adoption of single-use technologies is no longer emerging — it is firmly established. Data from 360 Research Reports shows that over 85% of biologics manufacturers use at least one single-use system in their processes. At the same time, advanced therapies are accelerating this trend. In cell therapy manufacturing, approximately 45–50% of facilities rely entirely on single-use systems, highlighting the shift toward flexible, modular production. These applications require smaller batch sizes, higher flexibility and faster changeovers — all of which align closely with single-use solutions.
Nevertheless, they introduce new complexities in validation, scalability and process control. As these therapies move from development to commercialisation, the need for shared knowledge and practical experience becomes increasingly important. Understanding how others approach these challenges can significantly shorten the learning curve.
From upstream dominance to downstream acceleration
Upstream bioprocessing still accounts for the largest share of the market, accounting for over 50% of total market share according to Mordor Intelligence. However, the balance is beginning to shift. Downstream processing is rapidly catching up. With upstream productivity increasing, downstream processes must evolve to keep pace.
This is driving strong growth in technologies such as single-use chromatography systems and advanced filtration solutions. For professionals in the field, this shift is not just a statistic — it directly impacts process design, facility layout and investment decisions. Comparing solutions and discussing real-world performance becomes crucial in navigating these changes effectively.
The rise of data-driven bioprocessing
Another defining trend is the rapid adoption of digital technologies. Investment in digitalisation — including real-time monitoring, advanced analytics and AI-driven optimisation — is accelerating across the industry. According to Mordor Intelligence, segments such as sensors and analytical components are growing at over 16% annually. This highlights the shift toward smarter, more connected manufacturing environments, where real-time monitoring and data-driven decision-making play a central role.
Efficiency and flexibility as key drivers
Across all segments, the same core drivers continue to emerge. According to GlobeNewswire (Astute Analytica) companies report up to 40% reduction in capital expenditure (CAPEX) and operational savings up to approximately 30% in cleaning and validation costs. These factors explain why single-use technologies are not just growing, but reshaping how facilities are designed and operated. In a landscape where speed and adaptability are critical, these advantages translate directly into competitive value.
While the numbers clearly show strong growth, they also highlight increasing complexity. More technologies, more suppliers and more options mean that decision-making is becoming more challenging. Understanding the data is one thing — translating it into the right choices for your process, facility or organisation is another.
That is exactly where Single-Use Event Leiden 2026 comes in. Taking place at CORPUS Congress Centre, the event is positioned at the heart of innovation. Located in the Leiden Bio Science Park — the largest life sciences cluster in the Netherlands, home to over 200 organisations in life sciences — the venue is surrounded by the very ecosystem driving the industry forward.
This proximity to leading biotech companies, research institutes and organisations such as Leiden University and LUMC creates a unique environment where knowledge, research and industry come together. In addition, the central location in the Randstad — with direct access to major highways and close proximity to Schiphol Airport — makes the venue highly accessible for both national and international professionals.
In one focused day, visitors can explore the technologies driving market growth, discuss challenges with peers and evaluate solutions side by side — all within a setting that reflects the future of bioprocessing itself. Because in a rapidly evolving industry, it is not just about understanding the statistics — it is about making the right connections.
Secure your ticket today
Single-Use Event Leiden 2026 brings together suppliers, users and experts for one focused day of networking and insight. Don’t miss this opportunity to explore the latest innovations and connect with the market.
Get your ticketReferences
Mordor Intelligence (n.d.). Single-use bioprocessing market – growth, trends, and forecast. Retrieved from https://www.mordorintelligence.com/industry-reports/single-use-bioprocessing-market
360 Research Reports (n.d.). Single-use bioprocessing market report. Retrieved from https://www.360researchreports.com/market-reports/single-use-bioprocessing-market-214842
Precedence Research (n.d.). Single-use bioprocessing market size and forecast. Retrieved from https://www.precedenceresearch.com/single-use-bioprocessing-market
GlobeNewswire (2026). Single-use bioprocessing market projected to reach USD 122.92 billion by 2035 (Astute Analytica). Retrieved from https://www.globenewswire.com/news-release/2026/01/20/3222151/0/en/Single-Use-Bioprocessing-Market-Projected-to-Reach-US-122-92-Billion-by-2035-Supported-by-Expansion-of-Biomanufacturing-Capacity-Says-Astute-Analytica.html
Kadans Science Partner (n.d.). Leiden Bio Science Park – cluster overview. Retrieved from https://www.kadans.com/science-clusters/leiden-bio-science-park-leiden/
Leiden Bio Science Park (n.d.). About Leiden Bio Science Park. Retrieved from https://leidenbiosciencepark.nl
CORPUS Congress Centre (n.d.). About CORPUS Congress Centre. Retrieved from https://corpusexperience.nl
Partners of Single-Use Event Leiden 2026
Single-Use Event Leiden 2026
Registration website for Single-Use Event Leiden 2026Single-Use Event Leiden 2026marketing@aleapublishers.nl
Single-Use Event Leiden 2026marketing@aleapublishers.nlhttps://www.single-use.nu/170266
2026-09-16
2026-09-16
OfflineEventAttendanceMode
EventScheduled
Single-Use Event Leiden 2026Single-Use Event Leiden 20260.00EUROnlineOnly2019-01-01T00:00:00Z
To be announcedTo be announcedevent registration made easy
aanmelder.nl is the software partner for events.
Click here to discover the software.